title: Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib.
authors.forename: G
authors.initials: G
authors.lastname: Cervetti
authors.forename: S
authors.initials: S
authors.lastname: Galimberti
authors.forename: R
authors.initials: R
authors.lastname: Fazzi
authors.forename: F
authors.initials: F
authors.lastname: Papineschi
authors.forename: A
authors.initials: A
authors.lastname: Azzarà
authors.forename: P
authors.initials: P
authors.lastname: Simi
authors.forename: M
authors.initials: M
authors.lastname: Petrini
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D002869:Chromosome Aberrations / Q000139:chemically induced*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate